Company Description

Our approach to health is based on creating novel health solutions based on clinically tested strains with unique Mechanisms of Action.  Our strain selection process involves the identification of a specific health target, followed by the selection of unique bacterial mechanisms of action for that application. The specific KABP™ clinical strains have shown a robust capability to survive under harsh gastro-intestinal tract (G.I.) conditions. 

Find out about our full portfolio of formulations, including products for digestive, infant, cardiovascular, immune, cardiovascular, brain, and oral health at  www.kanekaprobiotics.com. 

Brands: Kaneka Probiotics • KABP™

Categories